Compounds > carbidopa

carbidopa and Acquired Autoimmune Hemolytic Anemia

carbidopa has been researched along with Acquired Autoimmune Hemolytic Anemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kemi, M; Kondo, M; Maki, E; Tanabe, K1
Bernstein, RM1

Other Studies

2 other study(ies) available for carbidopa and Acquired Autoimmune Hemolytic Anemia

ArticleYear
Influence of carbidopa, an aromatic amino acid decarboxylase inhibitor, on the development of autoimmune hemolytic anemia in NZB mice.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:2

    Topics: Anemia, Hemolytic, Autoimmune; Animals; Body Weight; Carbidopa; Coombs Test; Female; Hematocrit; Levodopa; Male; Methyldopa; Mice; Mice, Inbred NZB

1983
Reversible haemolytic anaemia after levodopa-carbidopa.
    British medical journal, 1979, Jun-02, Volume: 1, Issue:6176

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Parkinson Disease

1979